Pennant vs U S Physical Therapy
PNTG and USPH side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PNTG and USPH compare
Pennant and U S Physical Therapy are about the same size, with market caps of $1.5B and $1.3B.
Pennant grew revenue faster over the last twelve months (37.9% versus 11.3% for U S Physical Therapy).
U S Physical Therapy keeps more of each dollar of sales as profit, with a net margin of 4.0% compared with 2.9% at Pennant.
U S Physical Therapy pays a dividend yielding 2.1%; Pennant does not pay one.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PNTG | USPH |
|---|---|---|
| Size and price | ||
| Market cap | $1.5B | $1.3B |
| Share price | $41.66 | $85.83 |
| Change, 1 year | 66.4% | −2.6% |
| Change, 5 years | 75.0% | −21.2% |
| Beta (5Y) | 1.03 | 0.76 |
| Employees | 9,700 | 7,294 |
| StockData Score | ||
| Total score | 10 | 10 |
| Valuation score | 0 | 2 (better) |
| Growth score | 4 (better) | 2 |
| Performance score | 3 | 3 |
| Health score | 3 (better) | 2 |
| Dividend score | 0 | 1 (better) |
| Valuation | ||
| P/E | 46.3× | – |
| P/S | 1.3× (better) | 1.6× |
| P/B | – | 2.9× |
| EV/EBITDA | 20.6× | 15.0× (better) |
| P/FCF | 42.0× | 20.0× (better) |
| PEG | 0.82 | – |
| FCF yield | 2.4% | 5.0% (better) |
| Fair value | $33.43 | $80.34 |
| Margin of safety | −24.6% | −6.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 37.9% (better) | 11.3% |
| Revenue growth, 5Y average | 19.4% (better) | 13.0% |
| Net income growth (TTM) | 20.5% (better) | −15.6% |
| EPS growth (TTM) | 15.4% | – |
| EPS growth, 5Y average | 10.1% (better) | −10.6% |
| Profitability | ||
| Gross margin | 18.5% | 18.7% (better) |
| Operating margin | 5.6% | 9.4% (better) |
| Net margin | 2.9% | 4.0% (better) |
| FCF margin | 3.1% | 7.9% (better) |
| Return on equity | – | 6.8% |
| Return on invested capital | – | 8.9% |
| Financial health | ||
| Debt / equity | – | 0.49 |
| Net debt / EBITDA | −0.14 | 1.99 (better) |
| Interest coverage | 5.8× | – |
| Current ratio | 1.20 | 1.27 (better) |
| Altman Z-score | 2.82 (better) | 2.71 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | – | 2.1% |
| Years of dividend growth | – | 5 |
| Dividend growth, 5Y average | – | 41.3% |
| Shareholder yield | 0.00% | 2.1% (better) |
| Ownership | ||
| Held by institutions | 92.7% | 109% |
| Held by insiders | 5.0% | 2.6% |
| Insider net buying, 12 months | −$690K | −$173K (better) |
| Short interest, % of float | 3.6% | 8.9% |
Go deeper
- PNTG stock overview
- PNTG income statement
- PNTG valuation and score
- USPH stock overview
- USPH income statement
- USPH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.